Literature DB >> 27729268

Role of adenosine A2b receptor overexpression in tumor progression.

Cesar Sepúlveda1, Iván Palomo2, Eduardo Fuentes3.   

Abstract

The adenosine A2b receptor is a G-protein coupled receptor. Its activation occurs with high extracellular adenosine concentration, for example in inflammation or hypoxia. These conditions are generated in the tumor environment. Studies show that A2b receptor is overexpressed in various tumor lines and biopsies from patients with different cancers. This suggests that A2b receptor can be used by tumor cells to promote progression. Thus A2b participates in different events, such as angiogenesis and metastasis, besides exerting immunomodulatory effects that protect tumor cells. Therefore, adenosine A2b receptor appears as an interesting therapeutic target for cancer treatment.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  A2b receptor; Adenosine; Cancer; Immunosuppressive; Tumor

Mesh:

Substances:

Year:  2016        PMID: 27729268     DOI: 10.1016/j.lfs.2016.10.008

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  14 in total

Review 1.  Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy.

Authors:  Daixi Ren; Yuze Hua; Boyao Yu; Xin Ye; Ziheng He; Chunwei Li; Jie Wang; Yongzhen Mo; Xiaoxu Wei; Yunhua Chen; Yujuan Zhou; Qianjin Liao; Hui Wang; Bo Xiang; Ming Zhou; Xiaoling Li; Guiyuan Li; Yong Li; Zhaoyang Zeng; Wei Xiong
Journal:  Mol Cancer       Date:  2020-01-30       Impact factor: 27.401

2.  An in vivo RNAi screen uncovers the role of AdoR signaling and adenosine deaminase in controlling intestinal stem cell activity.

Authors:  Chiwei Xu; Brian Franklin; Hong-Wen Tang; Yannik Regimbald-Dumas; Yanhui Hu; Justine Ramos; Justin A Bosch; Christians Villalta; Xi He; Norbert Perrimon
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-18       Impact factor: 11.205

3.  Agonist-Dependent Coupling of the Promiscuous Adenosine A2B Receptor to Gα Protein Subunits.

Authors:  Jan Hendrik Voss; Andhika B Mahardhika; Asuka Inoue; Christa E Müller
Journal:  ACS Pharmacol Transl Sci       Date:  2022-05-03

4.  A2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models.

Authors:  Apple Hui Min Tay; Rubén Prieto-Díaz; Shiyong Neo; Le Tong; Xinsong Chen; Valentina Carannante; Björn Önfelt; Johan Hartman; Felix Haglund; Maria Majellaro; Jhonny Azuaje; Xerardo Garcia-Mera; Jose M Brea; Maria I Loza; Willem Jespers; Hugo Gutierrez-de-Teran; Eddy Sotelo; Andreas Lundqvist
Journal:  J Immunother Cancer       Date:  2022-05       Impact factor: 12.469

5.  Increased Extracellular Adenosine in Radiotherapy-Resistant Breast Cancer Cells Enhances Tumor Progression through A2AR-Akt-β-Catenin Signaling.

Authors:  Hana Jin; Jong-Sil Lee; Dong-Chul Kim; Young-Shin Ko; Gyeong-Won Lee; Hye-Jung Kim
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

6.  The A2B Adenosine Receptor Modulates the Epithelial- Mesenchymal Transition through the Balance of cAMP/PKA and MAPK/ERK Pathway Activation in Human Epithelial Lung Cells.

Authors:  Chiara Giacomelli; Simona Daniele; Chiara Romei; Laura Tavanti; Tommaso Neri; Ilaria Piano; Alessandro Celi; Claudia Martini; Maria L Trincavelli
Journal:  Front Pharmacol       Date:  2018-01-31       Impact factor: 5.810

7.  A Novel Method for Screening Adenosine Receptor Specific Agonists for Use in Adenosine Drug Development.

Authors:  Karlie R Jones; Uimook Choi; Ji-Liang Gao; Robert D Thompson; Larry E Rodman; Harry L Malech; Elizabeth M Kang
Journal:  Sci Rep       Date:  2017-03-20       Impact factor: 4.379

8.  Adenosine A2A receptor ligand recognition and signaling is blocked by A2B receptors.

Authors:  Sonja Hinz; Gemma Navarro; Dasiel Borroto-Escuela; Benjamin F Seibt; York-Christoph Ammon; Elisabetta de Filippo; Azeem Danish; Svenja K Lacher; Barbora Červinková; Muhammad Rafehi; Kjell Fuxe; Anke C Schiedel; Rafael Franco; Christa E Müller
Journal:  Oncotarget       Date:  2018-02-06

9.  Development of a Radiofluorinated Adenosine A2B Receptor Antagonist as Potential Ligand for PET Imaging.

Authors:  Marcel Lindemann; Rareş-Petru Moldovan; Sonja Hinz; Winnie Deuther-Conrad; Daniel Gündel; Sladjana Dukic-Stefanovic; Magali Toussaint; Rodrigo Teodoro; Cathleen Juhl; Jörg Steinbach; Peter Brust; Christa E Müller; Barbara Wenzel
Journal:  Int J Mol Sci       Date:  2020-04-30       Impact factor: 5.923

Review 10.  Targeting Adenosine Receptor Signaling in Cancer Immunotherapy.

Authors:  Kevin Sek; Christina Mølck; Gregory D Stewart; Lev Kats; Phillip K Darcy; Paul A Beavis
Journal:  Int J Mol Sci       Date:  2018-12-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.